• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Tuesday 05/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • Stock News Today
    3:37 PM

    Cerebain Biotech (OTCQB: CBBT) today announced that Governor Scott McCallum, former governor of Wisconsin, has received an invitation and will be participating in a US-Poland Health Care Summit. The conference will begin on June 17, 2016 and be held in Warsaw, Poland. Governor McCallum will be presenting his research on healthcare innovation to a conference organized by the Federation of Polish Hospitals and the US Embassy. His presentation will include Cerebain’s efforts to develop a novel approach to the treatment

    Read more
  • 2:33 PM

    Heracles Pharma Seeks to Develop Strategic Partnerships with Pharmaceutical Industry in Pursuit of FDA Approval and Commercialization of X-22 Very Low Nicotine Smoking Cessation Product CLARENCE, N.Y.– XXII, (BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that 22nd Century has launched a new website atwww.heraclespharma.com to highlight the Company’s X-22 Very Low Nicotine smoking cessation cigarette in development. With 95% less nicotine than conventional tobacco, X-22

    Read more
  • 2:12 PM

    SAN DIEGO, May 24, 2016 /PRNewswire/ RGBP — Regen BioPharma, Inc., (OTCBB: RGBP), (OTCPINK: RGBP) and (OTCPINK: RGBPP) has applied to OTC Markets Group Inc. to uplist Regen’s Common and Series A Preferred shares to the OTCQB Venture Marketplace.  To be eligible to trade over the OTCQB, companies must be current in their reporting and undergo an annual verification and management certification process. “Our management team believes that having the Company’s shares trade over the OTCQB will enhance  Regen’s ability

    Read more
  • 2:35 PM

    RIVER EDGE, NJ / ACCESSWIRE / May 23, 2016 /NEPH,  Nephros, Inc. (OTCQB: NEPH), (the “Company”) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced today that it has signed a distribution agreement with CS Medical, LLC, a leader in developing, manufacturing, and marketing medical devices designed to provide high-level disinfection of ultrasound Trans-Esophageal Echocardiogram (“TEE”) probes. CS Medical’s TD 100® Automated TEE Probe Disinfector is designed to provide high-level disinfection for delicate

    Read more
  • 1:49 PM

    CLARENCE, N.Y., XXII –(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the Company has launched a new line of Research Cigarettes with varying levels of nicotine. Similar to the Company’s SPECTRUM® brand research cigarettes that are sold only to the National Institute on Drug Abuse (NIDA), 22nd Century’s new proprietary Research Cigarettes are available directly to accredited scientists, researchers, universities and governments – worldwide. 22nd Century

    Read more
  • 2:35 PM

    ORLANDO, Fla., May 19, 2016, IMUN, /PRNewswire/ — Immune Therapeutics, Inc. (OTCQB: IMUN ), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and non-infectious diseases, such as HIV/AIDS and cancer, with a focus on emerging nations, today announced its attendance at the 69th World Health Assembly ( ” WHA ” ) in Geneva, Switzerland to promote LodonalTM. The WHA is the decision-making body of the World Health Organization (“WHO”). It is attended by delegations from all WHO member

    Read more
Public Wire Banner